Category archive
Context-rich coverage of off-label drugs, metabolic interventions, and prescription longevity debates.
Articles in this cluster
9
What you will find here
Use this hub to jump into the most relevant profile, protocol, or explainer article in this topic area, then continue into related pieces for broader context.
Rapamycin has become one of the most discussed interventions in longevity research. Originally developed for transplant medicine, this mtor inhibitor has…
The promise of glp 1 microdosing longevity has captured attention from biohackers and clinicians alike. Originally developed to treat diabetes and…
A diabetes drug originally designed to control blood sugar is now generating serious interest in aging research circles. Acarbose, an alpha glucosidase…
The search for interventions that extend lifespan has led researchers to an unexpected compound: 17-alpha estradiol (17α-E2), a naturally occurring form…
Few medications have been studied as extensively as statins. Since their introduction in the late 1980s, these cholesterol-lowering drugs have become a…
The field of longevity medicine has moved beyond supplements and lifestyle hacks into serious pharmaceutical territory. Prescription longevity drugs now…
Can a diabetes drug extend human lifespan? This question sits at the heart of one of the most heated debates in aging research today.
Rapamycin has emerged as one of the most discussed compounds in longevity medicine, with studies showing 9-14% lifespan extension in mice and promising…
The search for interventions that slow aging has moved from folklore to rigorous science. Among the compounds showing genuine promise, acarbose stands out…